Nano Trends – A Journal of Nano Technology & Its Applications Original Research

Synthesis and Characterization of PF-127 Stabilized Metformin Encapsulated Chitosan-TPP Nanoparticles

  1. Sakshi Tyagi Centre for Emerging Diseases, Department of Biotechnology, Jaypee Institute of Information Technology, Noida
  2. Shalini Mani Department of Biotechnology, Jaypee Institute of Information Technology, Noida

Abstract

Metformin is widely used to manage Type 2 Diabetes, but its effectiveness is limited by low intestinal absorption, high dose requirements, and a short half-life. To tackle these challenges, several nano-drug delivery systems have been designed to optimize the delivery of metformin and enhance its therapeutic efficacy. Nanoparticles (NPs) have emerged as key players in medicine, biology, and pharmacology, gaini considerable attention for their potential applications. Polymeric NPs are among the most commonly utilized nanomaterials in nanomedicine due to their diverse applications. Chitosan (CS)-based polymeric NPs offer several key benefits, includingm biodegradability, biocompatibility, non-toxicity, bioactivity, ease of synthesis, and targeted delivery, making them highly suitable as drug carriers. CS NPs formed through ionic gelation are amongst the most studied nanosystems for drug delivery. Chitosan is also widely recognized as an effective nmucoadhesive polymer, capable of enhancing the bioavailability of drugs and improving cellular permeability. In this study, metformin-loaded chitosan TPP nanoparticles, stabilized by PF-127, were formulated, and characterized. We have incorporated the Ionic Gelation method for the formulation of nanoparticles. Physiochemical analyses such as FTIR and DLS were conducted. From the FTIR results, the successful synthesis of nanoparticles was confirmed. Also, the formulated nanoparticles showed mean hydrodynamic size of 188.8 nm, a zeta potential of -18.3 mV, and a drug entrapment efficiency of up to 41%.

Keywords

References (18)

  1. Lin X, Xu Y, Pan X, Xu J, Ding Y, Sun X, et al. Global, regional, and national burden and trend of diabetes in 195 countries and territories: an analysis from 1990 to 2025. Scientific Reports. 2020;10(1). doi:10.1038/s41598-020-71908-9
  2. Arafa K, Shamma RN, El-Gazayerly ON, El-Sherbiny IM. Facile development, characterization, and optimization of new metformin-loaded nanocarrier system for efficient colon cancer adjunct therapy. Drug Dev Industl Pharma. 2018 Jul 3;44(7):1158–70. https://doi.org/10.1080/03639045.2018.14384634
  3. Liang X, Giacomini KM. Transporters Involved in Metformin Pharmacokinetics and Treatment Response. Journal of Pharmaceutical Sciences. 2017;106(9):2245-2250. doi:10.1016/j.xphs.2017.04.078
  4. Chen Y, Shan X, Luo C, He Z. Emerging nanoparticulate drug delivery systems of metformin. Journal of Pharmaceutical Investigation. 2020;50(3):219-230. doi:10.1007/s40005-020-00480-1
  5. Zahin N, Anwar R, Tewari D, Kabir MT, Sajid A, Mathew B, et al. Nanoparticles and its biomedical applications in health and diseases: special focus on drug delivery. Environmental Science and Pollution Research. 2019;27(16):19151-19168. doi:10.1007/s11356-019-05211-0
  6. Miladi K, Sfar S, Fessi H, Elaissari A. Nanoprecipitation Process: From Particle Preparation to In Vivo Applications. Polymer Nanoparticles for Nanomedicines. 2016:17-53. doi:10.1007/978-3-319-41421-8_2
  7. Ekladious I, Colson YL, Grinstaff MW. Polymer–drug conjugate therapeutics: advances, insights and prospects. Nature Reviews Drug Discovery. 2018;18(4):273-294. doi:10.1038/s41573-018-0005-0
  8. Schmitt V, Kesch C, Jackson JK, Bidnur S, Beraldi E, Yago V, et al. Design and Characterization of Injectable Poly(Lactic-Co-Glycolic Acid) Pastes for Sustained and Local Drug Release. Pharmaceutical Research. 2020;37(3). doi:10.1007/s11095-019-2730-4
  9. Sangnim T, Dheer D, Jangra N, Huanbutta K, Puri V, Sharma A. Chitosan in Oral Drug Delivery Formulations: A Review. Pharmaceutics. 2023;15(9):2361. doi:10.3390/pharmaceutics15092361
  10. Jafernik K, Ładniak A, Blicharska E, Czarnek K, Ekiert H, Wiącek AE, et al. Chitosan-Based Nanoparticles as Effective Drug Delivery Systems—A review. Molecules. 2023;28(4):1963. doi:10.3390/molecules28041963
  11. Jiménez-Gómez CP, Cecilia JA. Chitosan: A Natural Biopolymer with a Wide and Varied Range of Applications. Molecules. 2020;25(17):3981. doi:10.3390/molecules25173981
  12. Hisham F, Maziati Akmal MH, Ahmad F, Ahmad K, Samat N. Biopolymer chitosan: Potential sources, extraction methods, and emerging applications. Ain Shams Engineering Journal. 2024;15(2):102424. doi:10.1016/j.asej.2023.102424
  13. Khan I, Saeed K, Khan I. Nanoparticles: Properties, applications and toxicities. Arabian Journal of Chemistry. 2019;12(7):908-931. doi:10.1016/j.arabjc.2017.05.011
  14. Joudeh N, Linke D. Nanoparticle classification, physicochemical properties, characterization, and applications: a comprehensive review for biologists. Journal of Nanobiotechnology. 2022;20(1). doi:10.1186/s12951-022-01477-8
  15. Hoang NH, Le Thanh T, Sangpueak R, Treekoon J, Saengchan C, Thepbandit W, et al. Chitosan Nanoparticles-Based Ionic Gelation Method: A Promising Candidate for Plant Disease Management. Polymers. 2022;14(4):662. doi:10.3390/polym14040662
  16. El-Naggar NEA, Shiha AM, Mahrous H, Mohammed ABA. Green synthesis of chitosan nanoparticles, optimization, characterization and antibacterial efficacy against multi drug resistant biofilm-forming Acinetobacter baumannii. Scientific Reports. 2022;12(1). doi:10.1038/s41598-022-24303-5
  17. Tiernan H, Byrne B, Kazarian SG. ATR-FTIR spectroscopy and spectroscopic imaging for the analysis of biopharmaceuticals. Spectrochimica Acta Part A: Moleculr Biomol Spectrospy. 2020 Nov 5;241:118636. https://doi.org/10.1016/j.sampre.2024.100122
  18. Alvarez-Ordóñez A, Halisch J, Prieto M. Changes in Fourier transform infrared spectra of Salmonella enterica serovars Typhimurium and Enteritidis after adaptation to stressful growth conditions. International Journal of Food Microbiology. 2010;142(1-2):97-105. doi:10.1016/j.ijfoodmicro.2010.06.008
Support